Skip to main content
. 2017 Feb 10;109(6):djw297. doi: 10.1093/jnci/djw297

Figure 2.

Figure 2.

Apoptosis and cell cycle analysis in lung cancer cells after CCT68127 treatment. A) Percentages of apoptotic cells after CCT68127 treatment of murine immortalized pulmonary epithelial (C10) and lung cancer (ED1, LKR13, and 393P) cells. Apoptosis induction after seliciclib treatment is shown for murine lung cancer cells. B) Percentages of apoptotic cells after CCT68127 treatment of human immortalized bronchial epithelial (Beas-2B) and lung cancer (H522, H1703, A549, and Hop62) cells. C) Cell cycle analysis after CCT68127 treatment in murine (ED1 and LKR13) and human (H522 and Hop62) lung cancer cells. Error bars are standard deviation. The P values were computed using t test (B) with multiple comparison adjustment by Dunnett's method (A and C). All statistical tests were two-sided.